Kenyan healthtech MYDAWA raises US$9.6M for growth in Kenya and Uganda

KENYA— Kenyan digital health startup MYDAWA has secured US$9.6 million in its latest funding round, marking its fifth successful raise since launching in 2017.

The round was led by Denmark’s Investment Fund for Developing Countries (IFU), with participation from private equity firm Alta Semper Capital, Singaporean investment group AAIC Investment, French family office Creadev, and Japan’s Ohara Pharmaceutical Co.

MYDAWA operates a “bricks and clicks” model, blending both physical pharmacies and a robust e-commerce platform to deliver healthcare services in Kenya and Uganda.

With this new capital, the company plans to open 10 additional pharmacies in Kenya and 30 in Uganda, with half of the Ugandan outlets located outside the capital, Kampala.

These physical expansions are complemented by investments in MYDAWA’s digital offerings, including online doctor consultations, e-prescriptions, and last-mile delivery of medications.

The startup’s integrated platform already provides a seamless experience for patients, combining virtual consultations, lab testing, chronic care management, and home delivery of medicines.

The new funding will also support the rollout of AI-driven tools to streamline inventory management, improve service efficiency, and lower costs for patients.

Additionally, MYDAWA aims to enhance its chronic disease care programs, providing more support for patients who require ongoing, affordable treatment.

Founded with US$1.5 million in seed funding from Indigo Partners, MYDAWA has steadily attracted international investors and partners.

In 2019, it received US$3 million from Indigo and AAIC Investment, and in 2021, the Bill & Melinda Gates Foundation contributed US$1.2 million.

Last year, MYDAWA raised US$20 million from Alta Semper Capital, which enabled it to acquire Guardian Health, a Ugandan pharmacy chain, and enter the Ugandan market by taking over 19 pharmacies.

MYDAWA’s growth is further supported by partnerships with major pharmaceutical companies such as Novo Nordisk, and its ability to supply hospitals across Kenya and Uganda.

The company also distributes HIV prevention pills to over 3,000 patients, with support from the Bill & Melinda Gates Foundation.

According to MYDAWA, its revenues are growing at 30% year-on-year, highlighting strong demand for its blended digital and physical healthcare services.

Looking ahead, MYDAWA’s leadership sees this latest round of funding as a vote of confidence in its vision to build the future of healthcare in Africa.

 The company’s founder, Neil O’Leary, emphasized that the caliber of investors joining the round demonstrates belief in MYDAWA’s scalable model and mission to expand access to quality healthcare across the continent.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.